62 related articles for article (PubMed ID: 7939510)
1. [Mortality following sustained ventricular tachycardia treated according to the results of programmed ventricular stimulation].
Chételat CA; Fromer M; Schläpfer J; Kappenberger L
Schweiz Med Wochenschr; 1994 Aug; 124(33):1430-6. PubMed ID: 7939510
[TBL] [Abstract][Full Text] [Related]
2. Impact of atrioventricular node ablation and pacing therapy on clinical course in patients with permanent atrial fibrillation and unstable ventricular tachycardia induced by rapid ventricular response: follow-up study.
Petrac D; Radićc B; Radeljić V; Hamel D; Filipović J
Croat Med J; 2005 Dec; 46(6):929-35. PubMed ID: 16342346
[TBL] [Abstract][Full Text] [Related]
3. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
4. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
[TBL] [Abstract][Full Text] [Related]
5. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
6. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
[TBL] [Abstract][Full Text] [Related]
7. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
Sweeney MO; Wathen MS; Volosin K; Abdalla I; DeGroot PJ; Otterness MF; Stark AJ
Circulation; 2005 Jun; 111(22):2898-905. PubMed ID: 15927965
[TBL] [Abstract][Full Text] [Related]
8. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.
Carbucicchio C; Santamaria M; Trevisi N; Maccabelli G; Giraldi F; Fassini G; Riva S; Moltrasio M; Cireddu M; Veglia F; Della Bella P
Circulation; 2008 Jan; 117(4):462-9. PubMed ID: 18172038
[TBL] [Abstract][Full Text] [Related]
9. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
Becker R; Haass M; Ick D; Krueger C; Bauer A; Senges-Becker JC; Voss F; Hilbel T; Niroomand F; Katus HA; Schoels W
Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
[TBL] [Abstract][Full Text] [Related]
10. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator.
Belhassen B; Ohayon-Tsioni T; Glick A; Viskin S
Isr Med Assoc J; 2009 Sep; 11(9):520-4, 526, 528. PubMed ID: 19960844
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.
Aizer A; Stern EH; Gomes JA; Teirstein AS; Eckart RE; Mehta D
Am J Cardiol; 2005 Jul; 96(2):276-82. PubMed ID: 16018857
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
13. [Ventricular tachycardia of ischemic cardiomyopathies].
Leclercq JF
Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):739-46. PubMed ID: 8267501
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
[TBL] [Abstract][Full Text] [Related]
16. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.
Di Biase L; Gasparini M; Lunati M; Santini M; Landolina M; Boriani G; Curnis A; Bocchiardo M; Vincenti A; Denaro A; Valsecchi S; Natale A; Padeletti L;
J Am Coll Cardiol; 2008 Oct; 52(18):1442-9. PubMed ID: 19017510
[TBL] [Abstract][Full Text] [Related]
18. [Arrhythmia recurrence in patients with an old myocardial infarct treated by implantable defibrillator: an analysis according to the initial clinical presentation].
Vacca M; Mont L; Valentino M; Sambola A; Madariaga R; Matas M; Brugada J
Rev Esp Cardiol; 1999 Dec; 52(12):1066-74. PubMed ID: 10659653
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
[TBL] [Abstract][Full Text] [Related]
20. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
